Pfiz­er will in­vest $1.2B+ in Irish man­u­fac­tur­ing site, adding 500 em­ploy­ees

Covid-19 trail­blaz­er Pfiz­er has con­firmed its com­mit­ment to a large ex­pan­sion project on the Emer­ald Isle.

The New York-based com­pa­ny an­nounced on Thurs­day that it will make a €1.2 bil­lion ($1.26 bil­lion) cap­i­tal in­vest­ment in­to its man­u­fac­tur­ing site at Grange Cas­tle in Dublin.

The ex­pan­sion of the site marks Pfiz­er’s largest ex­pan­sion in­vest­ment in Ire­land to date. The ex­pan­sion in­cludes the con­struc­tion of a new fa­cil­i­ty on the premis­es as well as adding in more lab­o­ra­to­ry space and will ul­ti­mate­ly dou­ble the ca­pac­i­ty for “bi­o­log­i­cal drug sub­stance man­u­fac­tur­ing” in the on­col­o­gy and rare dis­ease space as well as in­flam­ma­tion, im­munol­o­gy and in­ter­nal med­i­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.